Akso Health Group Financial Statements
NASDAQ: AHGConsumer DiscretionaryBusiness ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Akso Health Group revenue and earnings
In fiscal 2026, Akso Health Group generated $13.8 million in revenue, down 6.4% from fiscal 2025, its first annual decline since 2024. Akso Health Group reported a net loss of $18.7 million, compared with a loss of $135.0 million a year earlier. Gross margin was -0.1% (up from -1.9%) and operating margin -149.7%.
Diluted earnings per share came in at $0.01, down from $0.16. Over the last 5 fiscal years, AHG's revenue has grown at a 51.1% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Akso Health Group income statement (annual)
| Fiscal year (USD) | FY 20262026-03-31 | FY 20252025-03-31 | FY 20242024-03-31 | FY 20232023-03-31 | FY 20222022-03-31 | FY 20212021-03-31 | FY 20202020-03-31 | FY 20192019-03-31 | FY 20182018-03-31 | FY 20172017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.83M | 14.78M | 2.41M | 13.18M | 6.00M | 1.75M | 6.91M | 3.70M | 107.26M | 22.92M |
| Revenue growth (YoY) | -6.40% | +512.08% | -81.68% | +119.69% | +241.89% | -74.62% | +87.12% | -96.55% | +367.96% | — |
| Cost of Revenue | 13.84M | 15.06M | 2.29M | 11.91M | 5.39M | 544.57K | 1.03M | 7.40M | 8.50M | 5.15M |
| Gross Profit | -11.31K | -281.53K | 122.13K | 1.27M | 605.13K | 1.75M | 6.91M | -3.70M | 107.26M | 22.92M |
| Operating Expenses | 20.69M | 166.02M | 8.76M | 15.54M | 3.87M | 4.24M | 55.02M | 3.49M | 31.38M | 13.01M |
| Research & Development | — | — | — | — | 421.19K | 441.40K | 117.94K | 0 | 2.82M | 1.57M |
| Selling, General & Admin | 3.99M | 3.64M | 8.59M | 15.54M | 2.91M | 3.12M | 21.95M | 4.30M | 21.06M | 7.86M |
| Operating Income | -20.70M | -166.30M | -8.64M | -14.27M | -3.26M | -4.24M | -48.11M | -7.19M | 75.88M | 9.91M |
| Interest Expense | — | — | — | — | 804.14K | 2.15M | — | — | — | — |
| Other Income (Expense) | -4.11K | 34.07K | -453.75K | 1.20M | -747.82K | -52.08K | 1.23M | 381.15K | 660.88K | 179.53K |
| Pretax Income | -20.70M | -166.27M | -9.09M | -13.07M | -4.01M | -4.29M | -46.87M | -6.81M | 76.54M | 10.09M |
| Income Tax | -1.99M | -30.80M | 24.99K | 17.55K | 92.82K | 482.98K | 489.95K | 807.71K | 11.03M | 1.52M |
| Net Income | -18.67M | -134.98M | -9.46M | -1.36M | -16.85M | -34.83M | -71.20M | 5.53M | 65.48M | 8.57M |
| Net Income growth (YoY) | — | — | — | — | — | — | -1386.89% | -91.55% | +664.01% | +142.22% |
| EPS (Basic) | 0.01 | 0.16 | 0.07 | -0.02 | -0.28 | -0.71 | -1.46 | 0.11 | 1.46 | 0.20 |
| EPS (Diluted) | 0.01 | 0.16 | 0.07 | -0.02 | -0.28 | -0.71 | -1.46 | 0.10 | 1.37 | 0.20 |
| Shares Outstanding (Basic) | 2.17B | 855.29M | 141.52M | 68.60M | 59.61M | 48.84M | 48.76M | 48.69M | 44.98M | 42.33M |
| Shares Outstanding (Diluted) | 2.17B | 855.29M | 141.52M | 68.60M | 59.61M | 48.84M | 48.76M | 52.91M | 47.66M | 42.33M |
| EBITDA | -18.33M | -164.15M | — | — | -3.24M | -4.23M | -47.99M | -7.17M | 76.05M | 10.01M |
| Gross Margin | -8.00% | -1.91% | 5.06% | 9.63% | 10.09% | 100.00% | 100.00% | -100.17% | 100.00% | 100.00% |
| Operating Margin | -149.66% | -1125.37% | -357.78% | -108.23% | -54.34% | -241.68% | -695.72% | -194.55% | 70.74% | 43.25% |
| Net Margin | -134.99% | -913.38% | -391.78% | -10.32% | -280.85% | -1984.52% | -1029.70% | 149.72% | 61.05% | 37.39% |
This table shows 10 annual periods of Akso Health Group's income statement, from FY 2026 back to FY 2017, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow AHG's reporting calendar. What is a income statement?